Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A dynamic de-escalating dosing strategy to determine the optimal biological dose for antiangiogenic drugs.

× No keyword cloud information.

5 in total

Review 1. Maximum tolerated dose: clinical endpoint for a bygone era?

Authors: Chris H Takimoto
Journal: Target Oncol Date: 2009-04-18 Impact factor: 4.493

2. Low-dose metronomic oral dosing of a prodrug of gemcitabine (LY2334737) causes antitumor effects in the absence of inhibition of systemic vasculogenesis.

Authors: Giulio Francia; Yuval Shaked; Kae Hashimoto; John Sun; Melissa Yin; Carolyn Cesta; Ping Xu; Shan Man; Christina Hackl; Julie Stewart; Mark Uhlik; Anne H Dantzig; F Stuart Foster; Robert S Kerbel
Journal: Mol Cancer Ther Date: 2011-12-21 Impact factor: 6.261

3. Dose--schedule finding in phase I/II clinical trials using a Bayesian isotonic transformation.

Authors: Yisheng Li; B Nebiyou Bekele; Yuan Ji; John D Cook
Journal: Stat Med Date: 2008-10-30 Impact factor: 2.373

4. In vivo optical molecular imaging of vascular endothelial growth factor for monitoring cancer treatment.

Authors: Sung K Chang; Imran Rizvi; Nicolas Solban; Tayyaba Hasan
Journal: Clin Cancer Res Date: 2008-07-01 Impact factor: 12.531

5. Phase I Study Evaluating Dose De-escalation of Sorafenib with Metformin and Atorvastatin in Hepatocellular Carcinoma (SMASH).

Authors: Vikas Ostwal; Anant Ramaswamy; Vikram Gota; Prabhat G Bhargava; Sujay Srinivas; Bharati Shriyan; Shraddha Jadhav; Mahesh Goel; Shraddha Patkar; Sarika Mandavkar; Deepali Naughane; Anuprita Daddi; Chaitali Nashikkar; Nitin Shetty; Suman Kumar Ankathi; Shripad D Banavali
Journal: Oncologist Date: 2022-03-11

5 in total